D35.9
Benign neoplasm of endocrine gland, unspecified
Clinical Classification Guidelines
Inclusion Terms
- Benign neoplasm of unspecified endocrine gland
Medical Intelligence & Overview
A benign neoplasm of the endocrine gland, classified under ICD-10 code D35.9, refers to a non-cancerous growth that develops within one of the body's endocrine glands. The endocrine system plays a crucial role in regulating various bodily functions through hormone production. When a benign tumor forms in these glands, it generally grows slowly and does not spread to other parts of the body. Although usually not life-threatening, these growths can sometimes cause symptoms depending on their size and the specific gland involved. Because this diagnosis does not specify which endocrine gland is affected, the condition is termed ‘unspecified,’ indicating that further medical investigation may be necessary to determine the exact location and nature of the growth.
Causes & Symptoms
Clinical Causes: Genetic factors that influence cell growth and tumor formation Hormonal imbalances or irregularities Environmental influences such as exposure to certain chemicals or radiation Age-related cellular changes, particularly in middle-aged or older individuals Previous history of benign tumors in the endocrine system
Key Symptoms: Palpable or visible lump or swelling in the affected area Unusual hormone-related symptoms, which vary depending on the specific gland involved Symptoms related to hormonal excess, such as weight changes, fatigue, or temperature intolerance Local discomfort or pain if the tumor presses on surrounding tissues In some cases, no noticeable symptoms, and the tumor is discovered during routine examinations or imaging tests
Diagnostic & Treatment
Diagnosis Path: Physical examinations to check for lumps or swelling Imaging studies such as ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) to visualize the tumor Blood tests to assess hormone levels and identify functional effects of the growth Biopsy procedures to examine tissue samples and confirm the benign nature of the tumor Additional tests may be performed based on symptoms and initial findings
Treatment Protocols: Monitoring the tumor through regular imaging and blood tests if it is small and not causing symptoms Surgical removal, especially if the tumor is growing, causing symptoms, or there's uncertainty about its nature Medication to control hormone production if the tumor affects hormonal balance Following treatment, ongoing follow-up is essential to detect any recurrence or changes in the tumor
Clinical Advice & FAQs
Billing Guidance
Is D35.9 a billable ICD-10 code?
Yes, D35.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D35.9?
Clinical documentation must specify the nature of Benign neoplasm of endocrine gland, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference